Sandoz IRBESARTAN HCT 300/25 mg TABLETS : Sandoz Canada Inc. 02337444 : JR8726 : January 2022 : Losartan : AURO-LOSARTAN 100 mg TABLETS : Auro Pharma Inc. 02403358 : WB1019001-A : 14 August 2022 : ...

Sandoz is the generic division of Swiss drug maker Novartis. "We are exploring all possible options jointly with health authorities to facilitate a continuous supply of losartan to cover patient ...

Sandoz, along with FDA, ... Most recently, the FDA alerted providers about certain lots of irbesartan from SciGen Pharmaceuticals, owing to the presence of NDMA.

The agency pointed out that Sandoz’s losartan drug products make up less than 1% of the total ... the agencies have been testing other “sartan” products including candesartan, irbesartan, ...

The FDA announced Oct. 30 that ScieGen Pharmaceuticals has placed voluntary recalls on its irbesartan tablets in 75-, 150-, and 300-milligram dosage forms packed in 30- and 90- count bottles with ...

The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. Sandoz Inc. is voluntarily recalling losartan ...

Sandoz IRBESARTAN HCT 300/25 mg TABLETS : Sandoz Canada Inc. 02337444 : JR8726 : January 2022 : Losartan : AURO-LOSARTAN 100 mg TABLETS : Auro Pharma Inc. 02403358 : WB1019001-A : 14 August 2022 : ...

Sandoz IRBESARTAN HCT 300/25 mg TABLETS. Sandoz Canada Inc. 02337444. JR8726. January 2022. May 30, 2021. Losartan. AURO-LOSARTAN 100 mg TABLETS. Auro Pharma Inc. 02403358. WB1019001-A. 14 August ...